Assessment of postoperative outcomes of prescription benzodiazepine use in lung transplant recipients.

ABSTRACT:

Background

The use of prescribed benzodiazepine (BZD) has been associated with adverse outcomes, including morbidity and mortality, in certain groups of solid organ transplant recipients. However, its impact on outcomes in lung transplant patients has not been well established. This retrospective study explores the survival rates and mortality risk factors in lung transplant recipients with preoperative BZD prescriptions.

Methods

This study included an institutional lung transplant database between January 2018 and May 2024. Data were collected on patient characteristics, pretransplant laboratory values, and postoperative outcomes, including rejection and survival. Chi-squared, one-way analysis of variance (ANOVA), Kruskal-Wallis, Kaplan-Meier, and Wilcoxon signed-rank tests

SUBMITTER: Chang A 

PROVIDER: S-EPMC12268595 | biostudies-literature | 2025 Jun

REPOSITORIES: biostudies-literature